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Podocyte detachment and reduced endothelial cell
fenestration and relationships between these features and the
classic structural changes of diabetic nephropathy have not
been described in patients with type 2 diabetes. Here we
studied these relationships in 37 Pima Indians with type 2
diabetes of whom 11 had normal albuminuria, 16 had
microalbuminuria, and 10 had macroalbuminuria. Biopsies
from 10 kidney donors (not American Indians) showed almost
undetectable (0.03%) podocyte detachment and 43.5%
endothelial cell fenestration. In patients with type 2 diabetes,
by comparison, the mean percentage of podocyte detachment
was significantly higher in macroalbuminuria (1.48%) than in
normal albuminuria (0.41%) or microalbuminuria (0.37%).
Podocyte detachment correlated significantly with podocyte
number per glomerulus and albuminuria. The mean
percentage of endothelial cell fenestration was significantly
lower in macroalbuminuria (19.3%) than in normal
albuminuria (27.4%) or microalbuminuria (27.2%) and
correlated significantly with glomerular basement membrane
thickness, albuminuria, fractional mesangial area, and the
glomerular filtration rate (iothalamate clearance). Podocyte
detachment and diminished endothelial cell fenestration were
not correlated, but were related to classic lesions of diabetic
nephropathy. Thus, our findings confirm the important role
these injuries play in the development and progression of
kidney disease in type 2 diabetes, just as they do in type 1
diabetes. Whether podocyte detachment creates conduits for
proteins to escape the glomerular circulation and reduced
endothelial fenestration lowers glomerular hydraulic
permeability requires further study.
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Podocytes and glomerular endothelial cells are essential for
normal glomerular capillary permeability. Derangements of the
architecture of these cells have significant effects on kidney
function.1,2 In diabetic kidney disease, podocytes and glomer-
ular endothelial cells appear to participate in both the initiation
and progression of nephropathy.3–9 We reported previously that
podocyte loss is associated with diabetic nephropathy,10 that
it predicts progression of nephropathy at least as well as
mesangial expansion,11 and that loss of podocytes assessed by
serial kidney biopsy occurs during the transition from micro-
albuminuria to more advanced nephropathy.12
Podocyte detachment (PD) and reduced endothelial cell
fenestration (ECF) on electron microscopy and the quanti-
tative relationships between these features and the classic
structural changes of diabetic nephropathy have been
described in people with type 1 diabetes (T1DM)9 but not
in those with type 2 diabetes (T2DM). We used morpho-
metric methods to examine the relationship between PD and
reduced ECF and other structural and functional features of
diabetic nephropathy in 37 Pima Indians with T2DM. Ten
healthy kidney transplant donors, none of whom were
American Indians, served as controls.
RESULTS
Clinical characteristics of the 10 normal kidney donors (6
Caucasians, 2 Asian, and 2 African Americans) before
donation, and the 37 diabetic subjects (all American Indians)
at the renal clearance study closest to the kidney biopsy, are
summarized in Table 1. Mean fasting plasma glucose
concentration among the kidney donors was 87±8mg/dl.
Among the diabetic subjects, time between the clearance
study and the biopsy averaged 0.22 years (range¼ 0.02–0.55
years). Eleven subjects had normal urinary albumin excretion
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(albumin/creatinine ratio (ACR) o30mg/g), 16 had micro-
albuminuria (ACR¼ 30–299mg/g), and 10 had macroalbu-
minuria (ACRX300mg/g) at the time of the clearance study.
Diabetes duration (P¼ 0.002) and glycated hemoglobin
(HbA1c, P¼ 0.008) were greater in participants with micro-
albuminuria than in those with normoalbuminuria
(P¼ 0.008). Glomerular filtration rate (GFR) was highest in
those with microalbuminuria (P¼ 0.030 vs. normoalbumi-
nuria, P¼ 0.004 vs. macroalbuminuria). A minority of
normoalbuminuric participants and a majority of microalbu-
minuric and macroalbuminuric participants (Table 1) were
prescribed angiotensin-converting enzyme inhibitors and/or
angiotensin receptor blockers. Some were also prescribed
other antihypertensive medicines, especially diuretics.
The structural characteristics are described in Table 2.
Among subjects with diabetes, those with macroalbuminuria
had higher percentage of fractional interstitial area (P¼ 0.01 vs.
normoalbuminuria, P¼ 9.1 104 vs. microalbuminuria),
higher fractional mesangial area (P¼ 3.8 104 vs. normo-
albuminuria, P¼ 5.6 104 vs. microalbuminuria), wider
glomerular basement membranes (GBMs; P¼ 4.8 103 vs.
normoalbuminuria, P¼ 0.05 vs. microalbuminuria), lower
filtration surface area density (P¼ 4.8 103 vs. normoalbu-
minuria, P¼ 4.1 103 vs. microalbuminuria), and lower total
filtration surface area (P¼ 0.03 vs. normoalbuminuria,
P¼ 8.7 103 vs. microalbuminuria). Podocyte number was
lower with higher levels of albuminuria, but not significantly so.
Mean percentage of PD was higher in participants with
macroalbuminuria (1.48%) than in those with normoalbu-
minuria (0.41%; P¼ 0.04) or microalbuminuria (0.37%;
P¼ 0.02). Mean percentage of normal ECF was lower in the
macroalbuminuric group (19.3%) than in those with
normoalbuminuria (27.4%; P¼ 0.01) or microalbuminuria
(27.2; P¼ 5.0 103). PD was virtually nonexistent (0.03%)
and ECF was 43.5% in normal kidney donors. Figures 1 and 2
illustrate PD and abnormal ECF in T2DM. The percentage of
normal ECF directly across the GBMs from detached
podocytes was 37.0% in the diabetic subjects, and the overall
percentage of normal ECF was 27.2% in the same subjects
(P¼ 0.09).
Spearman’s correlations between structural and functional
parameters for diabetic subjects are shown in Table 3;
relationships between PD or ECF and functional character-
istics are shown in Figure 3. Fractional mesangial area
correlated positively with ACR (r¼ 0.55, Po0.001) and
negatively (r¼0.35, P¼ 0.036) with GFR. Total surface area
correlated positively with GFR (r¼ 0.49, P¼ 0.002). Foot
process width correlated positively with ACR (r¼ 0.55,
Po0.001), GBM width (r¼ 0.38, P¼ 0.020), and fractional
mesangial area (r¼ 0.59, Po0.001). The percentage of PD
correlated positively with ACR (r¼ 0.36, P¼ 0.028) and
negatively with podocyte number per glomerulus (r¼0.41,
P¼ 0.011). The percentage of fenestrated endothelium corre-
lated negatively with GBM width (r¼0.38, P¼ 0.019),
fractional interstitial area (r¼0.33, P¼ 0.049), fractional
mesangial area (r¼0.54, Po0.001), and ACR (r¼0.45,
P¼ 0.006), and positively with filtration surface area density
(r¼ 0.65, Po0.001) and GFR (r¼ 0.44, P¼ 0.006). The
percentages of PD and ECF were not correlated (r¼0.25,
P¼ 0.131).
DISCUSSION
PD and reduced glomerular ECF are quantifiable structural
features of nephropathy in T2DM that correlate positively
with ACR and worsen in parallel with the classic structural
features of diabetic kidney disease. Reduced glomerular ECF
also correlates negatively with GFR. This is the first study to
demonstrate an association between loss of normal ECF and
declining GFR. We confirm that increasing PD correlates
positively with increasing albuminuria, as shown in T1DM.9
PD correlated negatively with podocyte number per
glomerulus, a finding consistent with previous reports of
Table 1 | Patient characteristics at biopsy from 37 Pima Indians with type 2 diabetes mellitus
Donors (n=10)
Normoalbuminuric
(n=11)
Microalbuminuric
(n=16)
Macroalbuminuric
(n=10) P-values
Fraction of
females
5/10 10/11 11/16 5/10 0.064a, 0.425b, 1.000c, 0.350d, 0.064e, 0.425f
Age (years) 47±11.7 45.7±11.0 48.1±9.0 48.3±7.3 0.959a, 0.806b, 1.000c, 0.512d, 0.605e, 0.698f
BMI (kg/m2) 25.2±3.2 35.9±7.7 35.5±8.5 34.5±8.0 6.8 105a, 2.5 104b, 0.002c, 0.716d, 0.512e, 0.897f
Duration (years) NA 12.6±3.0 16.4±7.2 19.8±5.4 NAa, NAb, NAc, 0.178d, 0.002e, 0.100f
HbA1c (%) NA 7.7 ±1.4 8.4±2.3 9.8±1.6 NAa, NAb, NAc, 0.181d, 0.008e, 0.205f
MAP (mmHg) 92±11 88±8 94±9 98±15 0.512a, 0.542b, 0.363c, 0.131d, 0.173e, 0.525f
ACR (mg/g)g 5 (3–91) 19 (7–26) 61 (36–212) 978 (358–3762) —
GFR (ml/min) 110±24 127±48 172±56 111±49 0.191a, 0.002b, 0.670c, 0.030d, 0.314e, 0.004f
Antihypertensive
treatment (%)h
0 27.3 62.5 60.0 0.214a, 0.003b, 0.011c, 0.120d, 0.198e, 1.000f
Abbreviations: ACR, albumin-to-creatinine ratio; BMI, body mass index; GFR, glomerular filtration rate; HbA1c, glycated hemoglobin; MAP, mean arterial pressure; NA, not
applicable.
The P-values are shown for adonors vs. normoalbuminuric, bdonors vs. microalbuminuric, cdonors vs. macroalbuminuric, dnormoalbuminuric vs. microalbuminuric,
enormoalbuminuric vs. macroalbuminuric, fmicroalbuminuric vs. macroalbuminuric groups, gACR values by group are different by definition, and hantihypertensive treatment
included angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers in any patient receiving therapy, including the drug provided as part of the trial.
P-values o0.05 are shown in bold.
Data are means±s.d., median (range), or percent.
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reduced podocyte number and/or podocyte density in T1DM
and T2DM4–9,13 and with the presence of podocyturia in
patients with T2DM and diabetic nephropathy.14 PD also
correlated positively with albuminuria, whereas podocyte
number did not, providing further evidence to implicate
podocyte injury rather than podocyte loss as the primary
structural factor responsible for decreased permselectivity of
the glomerulus in diabetic nephropathy. Studies in Pima
Indians with T2DM found that subjects with macroalbu-
minuria had increased filtration of high-molecular-weight
Table 2 | Glomerular structural parameters from 10 normal kidney donors and 37 Pima Indians with type 2 diabetes mellitus
Donors (32
glomeruli)
Normoalbuminuric
(39 glomeruli)
Microalbuminuric
(64 glomeruli)
Macroalbuminuric
(39 glomeruli) P-values
General structural variables
Global sclerosis (%) 3.0±3.4 12±13 15±14 24±16 0.20a, 3.8 103b, 5.9 103c, 0.38d, 0.07e, 0.20f
Glomerular volume
( 106 mm3)
2.7±1.0 4.8±1.2 5.5±1.8 6.1±3.0 5.5 104a, 1.0 104b, 4.9 104c, 0.37d, 0.43e, 0.94f
Fractional interstitial
area (%)
10±3 25±6 25±5 34±7 5.7 106a, 3.8 107b, 1.1 105c, 0.57d, 0.01e, 9.1 104f
Fractional mesangial
area (%)
7.5±2 16±5 17±6 30±9 1.1 104a, 7.2 106b, 1.1 105c, 0.68d, 3.8 104e, 5.6 104f
Filtration surface area
density (mm2/mm3)
0.12±0.03 0.08±0.03 0.08±0.02 0.05±0.02 1.5 103a, 4.3 104b, 1.1 105c, 0.98d, 4.8 103e, 4.1 103f
Total surface area
( 105 mm2)
3.8±1.4 4.4±1.2 5.1±1.9 3.4±1.4 0.15a, 0.06b, 0.72c, 0.25d, 0.03e, 8.7 103f
GBM width (nm) 322±41 438±84 499±153 608±131 2.1 103a, 7.2 106b, 1.1 105c, 0.48d, 4.8 103e, 0.05f
Nonpodocyte cell
(number/glomerulus)
691±500 3214±1004 3989±1807 5363±2482 5.7 106a, 3.8 107b, 1.1 105c, 0.39d, 0.02e, 0.04f
Podocyte structural variables
Podocyte cell number/
glomerulus
880±316 686±249 644±295 611±168 0.22a, 7.3 103b, 0.02c, 0.48d, 0.60e, 0.94f
Filtration slit frequency
(slits/mm)
1507±154 1429±179 1348±154 1172±204 0.42a, 0.02b, 9.9 104c, 0.23d, 0.01e, 0.04f
Foot process width (nm) 429±49 441±61 484±57 599±174 0.85a, 0.01b, 6.9 104c, 0.09d, 2.1 103e, 0.05f
Podocyte detachment
(%)
0.03±0.05 0.41±0.56 0.39±0.57 1.48±1.56 0.05a, 0.05b, 3.6 103c, 0.81d, 0.04e, 0.02f
Endothelial fenestration variable
Fenestrated
endothelium (%)
43.5±5.1 27.4±5.5 27.2±5.7 19.3±6.5 2.3 105a, 2.6 106b, 2.2 105c, 0.98d, 0.01e, 5.0 103f
Abbreviation: GBM, glomerular basement membrane.
The P-values are shown for adonors vs. normoalbuminuric, bdonors vs. microalbuminuric, cdonors vs. macroalbuminuric, dnormoalbuminuric vs. microalbuminuric,
enormoalbuminuric vs. macroalbuminuric, and fmicroalbuminuric vs. macroalbuminuric groups. P-values o0.05 are shown in bold.
The number of glomeruli sampled in each group is shown.
Data are means±s.d.
CL
EC
P
RBC
PD
CL
WBC
RBC
PD
a b
Figure 1 |Peripheral glomerular capillaries illustrating intact
and detached podocyte foot processes from a
macroalbuminuric Pima Indian with type 2 diabetes mellitus,
transmission electron microscopy  11,280. (a) Intact
podocyte foot processes. (b) Podocyte foot process detachment.
CL, capillary lumen; EC, endothelial cell; P, podocytes foot
processes intact; PD, podocyte foot process detachment; RBC, red
blood cell; WBC, white blood cell.
CL
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a b
Figure 2 |Peripheral glomerular capillaries illustrating an
absence of normal endothelial cell fenestration, transmission
electron microscopy  11,280. (a) From a normal kidney donor,
with normal endothelial cell fenestration. (b) From a
normoalbuminuric Pima Indian with type 2 diabetes mellitus and
nonfenestrated endothelium. CL, capillary lumen; F, fenestrated
endothelial cell; NF, nonfenestrated endothelial cell; RBC, red
blood cell.
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dextrans through an excess of large pores that serve as
macromolecular shunts, whereas microalbuminuric subjects
had a shunt size no different from controls,15 suggesting that
low-grade albuminuria may result from a mechanism
different from nephrotic-range proteinuria. The significant
increase in PD in the macroalbuminuric subjects suggests
that these areas of detachment may represent the physical
substrate of the excess shunt magnitude, and complete
detachment of foot processes may occur along some portions
of the GBM without loss of the entire podocyte. PD also
correlated modestly, but not significantly, with declining
GFR. As we suggested previously, when foot processes
become detached, the remaining podocytes may spread their
foot processes more broadly to cover what would otherwise
be denuded basement membrane.10 This broadening of the
foot processes reduces filtration slit frequency, which in turn
should lower hydraulic permeability and probably GFR.15,16
The negative correlation that we found between PD and
filtration slit frequency is consistent with this scenario.
ECF was reduced significantly in normoalbuminuric
subjects compared with healthy kidney donors and, among
those with T2DM, loss of ECF correlated significantly with
albuminuria and GFR (Figure 3). Diminution of the
endothelial glycocalyx occurs with exposure to high glucose
concentrations. We speculate that the loss of this negatively
charged portion of the filtration barrier could then result in
the enhanced filtration of polyanionic albumin, which has
been reported both in vitro and in vivo.17,18 Loss of ECF may
represent another pathological response of endothelial cells to
hyperglycemia, but our fixation methods do not allow
investigation of whether the degree of ECF correlates with
the thickness of the glycocalyx. Lowered glomerular hydraulic
permeability due, in part, to a reduction in the density and
size of endothelial fenestrations is believed to be responsible
for the decline in GFR in pre-eclampsia,19 and may also
contribute to the decline in GFR in diabetes. The only other
morphometric variable to correlate significantly with both
albuminuria and GFR was fractional mesangial area, a
finding reported previously in T1DM20 and T2DM.10
Participants with diabetes had significantly fewer en-
dothelial fenestrae than nondiabetic kidney donors, yet the
GFR in those with normoalbuminuria or microalbuminuria
was higher (Table 2). This seeming paradox is explained, in
part, by diabetes-related glomerulomegaly increasing the
total filtration surface area, thereby offsetting declines in
glomerular hydraulic permeability caused by the reduced
fenestration and the diminished filtration surface area density
(Table 2).
The percentage of PD was determined by measuring the
fraction of the entire peripheral capillary GBM length
completely devoid of podocyte foot processes. Although we
did not measure PD along the perimesangial GBM, PD was
observed there as well. We defined PD as the complete
absence of foot processes, because we wanted to avoid
characterizing electron-lucent foot processes (which may
represent sublethal cell injury) as areas of detachment, asT
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filtration slit diaphragms between foot processes are still
potentially intact in these areas, and the functional
characteristics of the glomerular membrane potentially
remain unchanged.21 Moreover, we did not want to include
areas with a mixture of intact and detached foot processes in
our definition of detachment, because of uncertainties about
their effect on permselectivity. In comparison, Toyoda et al.9
counted areas including a mixture of intact and detached foot
processes (‘mixed’ foot processes) in their measurements of
detachment. These authors did not mention how electron-
lucent foot processes were characterized according to their
definitions of ‘attached,’ ‘detached,’ and ‘mixed.’ Accordingly,
they reported 22% PD, whereas our different definition
results in just over 1% PD. Regardless of these quantitative
differences, the two studies demonstrate a process common
to diabetic glomerulopathy in both T1DM and T2DM, but
absent in normal kidneys.22 Moreover, the two studies
demonstrate strong similarities in the relationship of PD
with the classic lesions of diabetic nephropathy and its
associated functional abnormalities.
Podocyte production of vascular endothelial growth factor
is important for the maintenance of normal ECF. Blocking
production of vascular endothelial growth factor or its
effector pathways decreases ECF, capillary permeability, and
GFR, and increases proteinuria.19,23–25 However, when we
specifically examined endothelium abutting sections of
basement membrane that were devoid of overlying foot
processes, we found no decrease in the mean proportion of
normal ECF compared with the overall proportion of normal
ECF, suggesting that loss of foot processes does not affect ECF
locally and that loss of ECF does not affect local foot process
attachment. One potential explanation is that impairment in
production and release of vascular endothelial growth factor
by podocytes may be independent of foot process detach-
ment. Indeed, PD was localized and limited, whereas
reduction in ECF was relatively widespread, especially in
macroalbuminuric subjects. Despite demonstrated podocyte–
endothelial crosstalk in some circumstances, these cellular
compartments appear to be differentially regulated (and
perturbed).
The present cross-sectional study was designed to assess
the functional and structural correlates of PD and loss of ECF
at various stages of diabetic kidney disease defined by level of
albuminuria. This comparison took place within an ongoing
clinical trial, and treatment with angiotensin blockade may
have affected the level of albuminuria. Moreover, although
albuminuria and GFR strongly predict progressive kidney
disease in diabetic Pima Indians,26 and the combination of
these functional variables is a better predictor of ESRD and
death than either measure alone,27 some investigators suggest
that microalbuminuria is an unreliable predictor of diabetic
nephropathy because it may regress spontaneously,28 and
albuminuria may never increase in some patients despite
worsening GFR.29 Accordingly, some caution should be
exercised in interpreting the relationship between these
structural and functional measures.
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Figure 3 |Correlations of albumin/creatinine ratio (ACR) or glomerular filtration rate (GFR) with percentage of podocyte
detachment or percentage of normally fenestrated endothelium. (a, b) ACR (Pearson’s r¼ 0.43, P¼ 0.009) and GFR (Pearson’s r¼0.29,
P¼ 0.084) as a function of percentage podocyte detachment in 37 Pima Indians with type 2 diabetes mellitus. The linear functions were not
changed substantially by omission of the two individuals with the greatest amount of podocyte detachment. GBM, glomerular basement
membrane. (c, d) ACR (Pearson’s r¼0.51, P¼ 0.001) and GFR (Pearson’s r¼ 0.45, P¼ 0.005) as a function of the percentage of normally
fenestrated endothelium in the same individuals. Regression lines and 95% confidence intervals are shown.
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Pima kidney transplant donors were not available to serve
as controls. Instead, morphometric measurements from
healthy nondiabetic Caucasian, African-American, and Asian
kidney donors were used for comparison. There were striking
structural differences between the normal kidney donors and
normoalbuminuric diabetic subjects in many stereological
and morphometric variables. However, in the absence of
information from nondiabetic Pima controls, conclusions
regarding genetic, environmental, or disease-based differ-
ences cannot be inferred with certainty.
The results of this study are likely to be applicable to other
populations. Previous studies in Pima Indians have provided
valuable, generalizable insights into the pathophysiology of
diabetic nephropathy. Aside from the larger size of glomeruli
in both diabetic and nondiabetic Pima Indians,30 the
observed structural changes of diabetic nephropathy are
indistinguishable from those in other populations. Moreover,
because details of the onset and duration of diabetes are
known with much greater precision than in other popula-
tions, and because nearly all kidney disease is attributable to
diabetes,31 findings in the Pima Indians may in fact offer a
clearer picture of the effects of T2DM on the kidney than can
be found in other populations.
In conclusion, we document PD and loss of ECF in
humans with T2DM even before the development of overt
nephropathy, and correlate these quantitative structural
variables with other glomerular structural and functional
characteristics of diabetic nephropathy. Our findings are
consistent with those reported previously in T1DM,9 and
confirm the important role that these distinct cellular injuries
may have in the development and progression of diabetic
glomerular disease in both T1DM and T2DM.
MATERIALS AND METHODS
Participants included 37 Pima Indians enrolled in a randomized,
placebo-controlled, clinical trial to evaluate the renoprotective
efficacy of losartan in T2DM (ClinicalTrials.gov number,
NCT00340678). This study was approved by the review board of
the National Institute of Diabetes and Digestive and Kidney
Diseases. Each participant gave informed consent. Subjects were
X18 years old at the time of enrollment in the trial. In addition to
the randomized study treatment, diabetes and other antihyperten-
sive therapies (including angiotensin-converting enzyme inhibitors)
were individualized for each patient by his or her primary care
provider. Subjects underwent annual measurements of kidney
function and a percutaneous kidney biopsy at the end of the
randomized treatment period (B6 years). Kidney biopsies were
performed under ultrasound guidance with a 15-gauge Easy Core
biopsy needle (Boston Scientific, Natick, MA). One or two cores of
the tissue were fixed in buffered 4% glutaraldehyde and shipped to
the Beckman Center for Electron Microscopy at Stanford University
where they were processed. Tissue was dehydrated through a series
of graded ethanols, and the fixed tissues were embedded in Epon 812
(Electron Microscopy Sciences, Hatfield, PA) before preparation for
light and electron microscopy.
Ten healthy, living kidney donors (not American Indians), who
consented to participate in a longitudinal study of kidney function
after donation, served as controls. After negative screening for
diabetes, hypertension, and proteinuria, GFR from the urinary
clearance of nonradioactive iothalamate was measured immediately
before donation.32
Measurements were made using strict stereologic and morpho-
metric methods to account for two-dimensional sampling of three-
dimensional objects, as described previously.10,11 To ensure rando-
mized sampling and the use of only one cross-sectional profile per
glomerulus, 0.5-mm sections taken at least 200mm (average
glomerular diameter) apart were cut, mounted on glass slides, and
stained with toluidine blue. For light microscopy, photomicrographs
were created at  273 and  2191 magnification. Those at  273
were used to count the number of patent and globally sclerotic
glomeruli in sections of cortical tissue. Only glomeruli contained
entirely within the core were studied. An average of 16 (range 5–79)
of these complete glomeruli per subject were included in the
measurements. An equation that takes into account the smaller
diameter of sclerotic glomeruli, and the consequent difference in the
probability of encountering a sclerotic or nonsclerotic glomerulus in
a random cross-section, was used to calculate the percentage of
sclerotic glomeruli.32 Photomicrographs at  273 were also used to
estimate glomerular volume (VG) from the cross-sectional area of at
least five nonsclerotic tufts using the Weibel–Gomez method. Average
glomerular tuft area for a group stabilizes after measurement ofB5
profiles per individual.33 Fifteen photomicrographs selected ran-
domly from the renal cortex at  2191 magnification were used to
determine the fractional interstitial area expressed as a percentage of
total cortical area by intercept counting, using a 15-mm counting grid
containing 225 cells. A total of 3375 intercepts were counted per
subject. Interstitial area was defined as any tissue, including
interstitial cells, outside of tubular and vascular structures larger
than peritubular capillaries. Glomerular profiles, large vessels, and
tubules plus interstitium were included in the reference cortical area.
For transmission electron microscopy, 0.5-mm sections stained
with toluidine blue were surveyed to identify X3 open glomerular
profiles. Further sections (70 nm thick) were cut and collected on
3-mm copper grids, stained with lead citrate and uranyl acetate,
and examined in a Hitachi H-600 transmission electron microscope
(Hitachi High-Tech, Pleasanton, CA). Low-power electron photo-
micrographs ( 2820) were obtained to complete a montage of each
glomerulus. Fractional mesangial area (AA), composed of both cells
and matrix and expressed as a percentage of total tuft area, was
determined by intercept counting on the  2820 montage micro-
graphs. Intercept counting using lines 20mm in length on the  2820
montage was used to determine the average peripheral capillary
filtration surface area density (SV), expressed as mm
2/mm3 (¼ 1/mm).
Total surface area was calculated as the product of SVVG.
Numerical volume density of podocytes per glomerulus was
determined using the Weibel–Gomez formula (b¼ 1.45 and
k¼ 1.1).16 The absolute number of podocyte nuclei per glomerulus
was then determined by multiplying the average glomerular tuft
volume by the numerical volume density of the podocytes. The
numbers of endothelial and mesangial cells per glomerulus were
determined by the same method (b¼ 1.5). Endothelial and
mesangial cell numbers were combined in the analysis because
distinctions between these cell types were not always possible. Twenty
high-power photomicrographs ( 11,280) were also obtained from
each glomerular profile. Harmonic mean GBM width was deter-
mined from the high-power ( 11,280) electron photomicro-
graphs.34 Filtration slit frequency, expressed as the number of slits
per mm of GBM, was determined by counting the total number of
slits and dividing it by the total length of peripheral capillary wall
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captured on the high-power electron micrographs.16,35–37 Average
foot process width for a section of peripheral capillary wall was
determined by dividing the total length of the peripheral capillary
wall by the number of slits covering the wall.
Podocyte detachment
The  11,280 images were used to determine the percentage of
GBMs denuded of foot processes (PD).21 PD was defined as an
absence of foot processes along the abluminal aspect of the GBMs.
This determination was limited to the podocytes covering the
peripheral capillary filtration surface of the GBMs, and did not
include foot processes covering the perimesangial GBMs. The
majority of these denuded areas were free of any podocyte
membrane or cytoplasm. An area of GBM was not considered
denuded if podocyte foot processes were distributed normally along
the GBM, but their cytoplasm appeared abnormal (that is, relatively
electron-lucent).21 Similarly, if only alternate foot processes were
electron-lucent, that portion of the capillary was not considered
denuded. The denuded length was divided by the total measured
length of the GBM along the filtration surface to calculate the
percentage of GBM length from which podocytes were detached.21
Endothelial fenestration
The percentage of ECF was calculated using an unbiased counting
grid (6.7 6.7mm) with fine parallel lines 120 nm apart and
one thick line for every 7 fine lines superimposed randomly onto
the  11,280 images. Sections of endothelium intersected by thick
grid lines were studied. If the intersected segment of endothelium had
no fenestrae for more than three fine lines (360 nm) on either side
of the intersection with the thick grid line, it was considered
unfenestrated. The percentage of normal ECF was calculated for each
individual by dividing the number of intersections that were normally
fenestrated by the total number of endothelial intersections counted.9
Endothelial fenestration opposite detached podocytes
Every  11,280 image (n¼ 74) showing a length of complete PD
was examined to determine the percentage of ECF directly across the
basement membrane denuded of podocytes using the same counting
grid and method used to determine the total percent ECF. As PD
was a rare event, the grid was placed nonrandomly to ensure
measurement of ECF directly opposite denuded areas. The
percentage of normal ECF opposite basement membranes denuded
of podocytes was compared with the percentage of normal ECF in
the same subjects.
Physiologic measures
Kidney function was measured annually in all diabetic subjects, and
the physiologic measures were obtained from the study closest to the
date of the kidney biopsy. Urinary albumin was measured by
nephelometric immunoassay.38 Urinary creatinine and serum
creatinine levels were measured by a modification of the Jaffe
reaction.39 Albumin excretion was determined by computing the
urinary ACR in an untimed urine specimen. GFR was measured by
the urinary clearance of nonradioactive iothalamate and expressed
in ml/min, that is, not normalized to body surface area, for reasons
discussed previously.40
Statistical analysis
In the morphometric analysis, glomerular variables for each
individual were calculated as the mean of all glomeruli evaluated
for that individual. Final data for each study group were expressed as
means±s.d., unless otherwise specified. The exact Wilcoxon two-
sample test was used uniformly for comparisons of continuous
variables between the study groups, as several variables were heavily
skewed; the exact Fisher’s test was used for dichotomous variables.
The Wilcoxon signed rank sum test was used to compare paired
differences. Spearman’s correlations were calculated between struc-
tural and functional variables. Pearson’s correlations were calculated
for selected linear functions. The analyses were carried out using
SAS version 9.1 (Cary, NC).
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